General Info

Headquartered in Plymouth, Minn., ev3 is a medical device company with an international customer base. The company is focused on developing endovascular technologies for minimally invasive treatments of cardiovascular, neurovascular and peripheral vascular diseases and disorders. The company s peripheral, peripheral vascular and cardio-peripheral devices are available in the United States, while its peripheral vascular and cardio-peripheral devices are available internationally. The company s products include self-expanding, balloon-expandable and un-mounted balloon-expandable stents; balloon angioplasty catheters; guide-wires, snares and accessories; thrombus management systems; and embolic protection devices. A public company, ev3 s shares are listed on the NASDAQ Stock Market under the ticker symbol EVVV.